Does Dr. WASEEM AHANGAR have financial conflicts of interest?

Dr. WASEEM AHANGAR (M.D) has received a total of $2,631 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $2,631 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. WASEEM AHANGAR?

According to CMS Open Payments data, Dr. WASEEM AHANGAR received funding from ASTRAZENECA PHARMACEUTICALS ($765), GLAXOSMITHKLINE ($507), and INSMED ($238).

Does Dr. WASEEM AHANGAR receive research grants or speaking fees?

Dr. WASEEM AHANGAR has received $2,631 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. WASEEM AHANGAR

M.DReal-Time Hydrated

Specialty: Internal Medicine, Pulmonary Disease

Practice Location: LIVERPOOL, NY 13088

NPI Number: 1619386695

LIFETIME INDUSTRY VALUE

$2,631

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AHANGAR is a verified Internal Medicine, Pulmonary Disease practitioner based in LIVERPOOL, NY.

Between 2021 and 2025, Dr. AHANGAR had an overall industry promotional and research financial footprint of $2,631 as recorded in the federal CMS Open Payments database.

$2,631 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AHANGAR's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $765 (representing 29.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$765

29.1%

GLAXOSMITHKLINE

Rank 2

$507

19.3%

INSMED

Rank 3

$238

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.